Search our Database of Scientific Publications and Authors

I’m looking for a
    Off-label uses of topical vitamin D in dermatology: a systematic review.
    J Cutan Med Surg 2014 Mar-Apr;18(2):91-108
    Background: Topical vitamin D is approved by the US Food and Drug Administration for the treatment of psoriasis but is also used off-label in the treatment of a variety of cutaneous diseases despite a lack of evidence-based guidelines.

    Objective: The objective of this study was to provide evidence-based clinical guidelines for the off-label use of topical vitamin D in the treatment of dermatologic disease.

    Methods: A systematic literature review was conducted via the MEDLINE, Embase, and CENTRAL databases for off-label uses of topical vitamin D analogues in the treatment of dermatologic disease other than psoriasis. The data were synthesized, and evidence-based recommendations were rendered according to the highest level of evidence available.

    Results: A total of 165 articles met the inclusion criteria. A moderate to strong recommendation was given for the use of topical vitamin D in combination with corticosteroids and phototherapy in vitiligo and as monotherapy for various ichthyoses, morphea, pityriasis alba, prurigo nodularis, and polymorphous light eruption. There is evidence showing that topical vitamin D is ineffective in the treatment of actinic keratosis, seborrheic keratosis, lichen planus, seborrheic dermatitis, alopecia areata, chemotherapy-induced alopecia, and hypertrophic scars.

    Conclusion: Topical vitamin D analogues have an important role in the off-label treatment of dermatologic disease, but higher quality studies are still required.

    Similar Publications

    Off-Label Uses of Topical Calcineurin Inhibitors.
    Skin Therapy Lett 2016 Jan;21(1):8-10
    Division of Dermatology & Cutaneous Sciences, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
    Topical calcineurin inhibitors (TCIs) have been proposed as an alternative, long-term treatment option to topical corticosteroids, without the side effects commonly associated with steroid use. Currently, TCIs are only approved for treatment of atopic dermatitis in patients 2 years of age or older. This article reviews the off-label uses of TCIs and their efficacy in the treatment of cutaneous diseases. Read More
    Topical treatments for scalp psoriasis.
    Cochrane Database Syst Rev 2016 Feb 26;2:CD009687. Epub 2016 Feb 26.
    Division of Evidence Based Medicine, Department of Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany, 10117.
    Background: People with chronic plaque psoriasis often have lesions on the scalp. Hair makes the scalp difficult to treat and the adjacent facial skin is particularly sensitive to topical treatments.

    Objectives: To assess the efficacy and safety of topical treatments for scalp psoriasis. Read More
    Topical treatments for chronic plaque psoriasis.
    Cochrane Database Syst Rev 2013 Mar 28(3):CD005028. Epub 2013 Mar 28.
    Centre for Health Economics, The University of York, York, UK.
    Background: Chronic plaque psoriasis is the most common type of psoriasis, and it is characterised by redness, thickness, and scaling. First-line management of chronic plaque psoriasis is with topical treatments, including vitamin D analogues, topical corticosteroids, tar-based preparations, dithranol, salicylic acid, and topical retinoids.

    Objectives: To compare the effectiveness, tolerability, and safety of topical treatments for chronic plaque psoriasis, relative to placebo, and to similarly compare vitamin D analogues (used alone or in combination) with other topical treatments. Read More
    Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review.
    J Eur Acad Dermatol Venereol 2012 May;26 Suppl 3:52-60
    Dermatology Department, Paul Sabatier University, Toulouse, France.
    Objective: The objective of this systematic review was to prepare for evidence-based recommendations on the use of vitamin D analogues, and their combination with topical steroids in psoriasis.

    Methods: Literature systematic review performed in May 2011. The Cochrane, PubMed and Embase databases were systematically searched with different combinations: including Psoriasis AND calcipotriol expanded to all vitamin D analogues. Read More